HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumiya Hirano Selected Research

spiropentaneacetic acid (SPAA)

1/2017Pathogenic characterization of Erysipelothrix rhusiopathiae Met-203 type SpaA strains from chronic and subacute swine erysipelas in Japan.
3/2014Prevalence of Met-203 type spaA variant in Erysipelothrix rhusiopathiae isolates and the efficacy of swine erysipelas vaccines in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumiya Hirano Research Topics

Disease

4Neoplasms (Cancer)
02/2005 - 08/2002
2Swine Erysipelas
01/2017 - 03/2014
1Erysipelas
03/2014
1Communicable Diseases (Infectious Diseases)
01/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2003
1Allergic Rhinitis
03/2002
1Blepharoptosis (Ptosis, Eyelid)
03/2002
1Conjunctivitis
03/2002
1Hypersensitivity (Allergy)
03/2002
1Rhinitis
03/2002

Drug/Important Bio-Agent (IBA)

5AntigensIBA
01/2017 - 03/2002
2spiropentaneacetic acid (SPAA)IBA
01/2017 - 03/2014
2VaccinesIBA
03/2014 - 01/2014
2Monoclonal AntibodiesIBA
02/2005 - 10/2003
1Histamine (Histamine Dihydrochloride)FDA Link
03/2002
1Substance PIBA
03/2002
1levocabastine (Bilina)FDA Link
03/2002

Therapy/Procedure

3Immunotherapy
02/2005 - 08/2002